Related content

Effects of Medroxyprogesterone Acetate on the Risk of Cardiovascular Disease in Postmenopausal Women Receiving Estrogen

By  

Vascular Disease Prevention, Vol. 2, Iss. 2, 2005-04 ,pp. : 99-106

Bentham Science Publishers

Access to resources Recommend Favorite

Race and Ethnicity, Obesity, Metabolic Health, and Risk of Cardiovascular Disease in Postmenopausal Women

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 5, 2015-05 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens

By Pérez-López Faustino R.   Cuadros-López José L.   Fernández-Alonso Ana M.   Cuadros-Celorrio Angela M.   Sabatel-López Rosa M.   Chedraui Peter  

Gynecological Endocrinology, Vol. 26, Iss. 7, 2010-07 ,pp. : 533-538

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular disease risk factors associated with low level of physical activity in postmenopausal Polish women

By Lwow F.  

Gynecological Endocrinology, Vol. 29, Iss. 7, 2013-07 ,pp. : 683-686

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy

By Kurdoglu Mertihan   Yildirim Mulazim   Kurdoglu Zehra   Erdem Ahmet   Erdem Mehmet   Bilgihan Ayse   Goktas Bulent  

Gynecological Endocrinology, Vol. 27, Iss. 8, 2011-08 ,pp. : 551-557

Informa Healthcare

Access to resources Recommend Favorite